Modelling treatment, age- and gender-specific recovery in

acute injury studies by Akacha, Mouna et al.
 University of Warwick institutional repository: http://go.warwick.ac.uk/wrap 
 
This paper is made available online in accordance with 
publisher policies. Please scroll down to view the document 
itself. Please refer to the repository record for this item and our 
policy information available from the repository home page for 
further information.  
To see the final version of this paper please visit the publisher’s website. 
Access to the published version may require a subscription. 
Author(s):  M Akacha, JL Hutton and S Lamb 
Article Title: Modelling Treatment, Age- and Gender-Specic Recovery 
in Acute Injury Studies 
Year of publication: 2010 
http://www2.warwick.ac.uk/fac/sci/statistics/crism/research/2010/paper
10-09 
Publisher statement:  None 
 
 
 
 
Modelling Treatment, Age- and Gender-Specific Recovery in
Acute Injury Studies
Mouna Akacha and Jane L. Hutton
Department of Statistics
University of Warwick, UK
Sallie E. Lamb
Warwick Medical School
University of Warwick, UK
May 17, 2010
Abstract
Background: Acute injury studies often measure physical ability repeatedly over
time through scores that have a finite range. This can result in a faster score change
at the beginning of the study than towards the end, motivating the investigation of
the rate of change. Additionally, the bounds of the score and their dependence on
covariates are often of interest.
Methods: We argue that transforming bounded data is not satisfactory in some
settings. Motivated by the Collaborative Ankle Support Trial (CAST), which inves-
tigated different methods of immobilisation for severe ankle sprains, we developed a
model under the assumption that the recovery rate at a specific time is proportional to
the current score and the remaining score. This model enables a direct interpretation
of the covariate effects. We have re-analyzed the CAST data using these improved
methods, and explored novel relationships between age, gender and recovery rate.
Results: We confirm that using below knee cast is advantageous compared with a
tubular bandage in relation with the recovery rate. An age and gender effect on the
recovery rate and the maximum achievable score is demonstrated, with older female
patients recovering less fast (age-effect: -0.21, 95% confidence interval (CI) [-0.28,-
0.14]; gender effect: -0.06, CI [-0.12,-0.004]) and achieving a lower maximum score
(age-effect: -8.07, CI [-11.68,-4.01]; gender-effect: -5.34, CI [-8.18, -2.50]) than younger
male patients.
Conclusions: Our model is able to accurately model repeated measurements on the
original scale, while accounting for the bounded nature of a score. We demonstrate
that recovery in acute injury trials can differ substantially by age and gender. Older
female patients are less likely to recover well from a sprain.
Keywords: Bounded scores, CAST-trial, non-linear mixed models, rate of recovery,
repeated measurements
Introduction
In medical research it is very common to measure physical or mental ability repeatedly
over time through questionnaires or scales. Based on the answers, summary measures
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such as scores can be derived for every point in time. In many applications, these scores
will have finite range, where one bound indicates ‘no symptoms’ and the other bound
‘extreme symptoms’. Examples are the Barthel index1, the Neck Disability Index 2,
the Foot and Ankle Outcome Score 3 (FAOS) and visual analogue scales. In studies
where we expect most patients to recover, we often observe that later measurements
are clustered towards one end of the range. In this case, different patients might have
the same initial and the same final scores. However, the rate at which they achieve the
final score might differ substantially dependent on explanatory variables, for example,
treatment or age. The bounds themselves can also be of scientific interest, e.g. a
maximum achievable score can differ substantially for different ages and genders.
For a continuous and bounded score, the classical approach is to transform the data
such that fitting a linear regression model seems reasonable. For some scores, however,
a non-linear dependence of the transformed outcome score on covariates persists due
to the bounded nature of the score. In addition, models based on transformations
cannot investigate the dependence of bounds on covariates as the bounds need to be
specified prior to the transformation. Using transformations can also complicate the
interpretation of covariate effects on the original score.
In this paper, we present a model for the outcome score on the original scale
as a function of covariates. The model is constructed for scores where the rate of
recovery changes over time and was motivated by the Collaborative Ankle Support
Trial (CAST), which is the first large randomized controlled trial comparing four
types of mechanical support for acute ankle sprains of sufficient severity to prevent
weight bearing.4–6
To show how this model was derived, we first introduce the motivating example in
more detail and give descriptive statistics. Subsequently, we introduce our statistical
model and apply it to the CAST dataset. Finally, we compare the inference based on
our model with those obtained from other approaches. We argue that our model en-
ables a more flexible investigation of covariate effects on rates of recovery and bounds.
In addition, our analysis enables the calculation of a variety of auxiliary information,
which we believe are of interest to patients suffering from acute soft tissue injuries.
The CAST Trial
The aim of the CAST study was to estimate the clinical and cost effectiveness of
three different methods of mechanical support after severe ankle sprain compared to
a standard treatment.4–6
The data for this trial were obtained from a randomised and multicentre study,
which was run in 6 National Health Service trusts (8 hospitals) across the UK. Patients
attending the selected emergency departments who had sustained a severe sprain of
the lateral ligament complex of the ankle, were unable to weight bear, aged 16 and
older, and gave informed consent were randomised in one of the four treatment groups
–Tubigrip (standard treatment), Below knee cast (BKC), Aircast brace and Bledsoe
boot.4 The clinical status of these patients was measured at four points in time (baseline
and follow-up: 4 weeks, 12 weeks and 9 months) via the FAOS questionnaire, which
contains 42 items and 5 subscales that ascertains functional limitations and the severity
of other symptoms after ligament sprains.3
A continuous score, with 100 indicating no symptoms and 0 indicating extreme
symptoms, was calculated for each subscale. The total sample size was N = 584. Due
to the fact that some patients did not receive the FAOS questionnaire but another
2
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Figure 1: Individual evolution of the FAOSS-score for a random subset of 10 patients. The dashed
lines correspond to patients with missing outcomes.
questionnaire called Ankle Performance Scale 7 (APS) during the baseline assessment,
the data of 553 persons instead of 584 persons will be investigated in this report.
Moreover, this analysis will concentrate on the symptoms-subscale score which will be
referred to as FAOSS-score (FAOS-symptoms score).
As with many studies which measure recovery from acute injuries, the natural
time course of recovery of ankle sprains is likely to stabilise within a certain period
(here: 3 to 9 months) and it is expected that the difference between the treatments
will narrow in the longer term because the majority of people will recover.4,8–10 An
important aim of treatment is to accelerate the rate of recovery. Understanding the
impact of explanatory covariates on the rate of recovery is important for guiding
patients and clinicians expectations.
The original analysis included randomisation group and adjusted for gender, age
and baseline score.4 The recovery was analysed at every time point separately, thus
neglecting the correlation between the four measurements of each subject. This can
reduce the precision of the analysis and thereby the significance of the results can be
overestimated.11 Additionally, the comparison of the different treatments was reduced
to per time point conclusions and did not enable an overall statement about the rate
of recovery.
For initial exploratory re-analysis, the individual evolution of the FAOSS-score
for a small subset of patients was plotted against time, see Figure 1. We connected
the four scores per subject to demonstrate the evolution over time. The dashed lines
correspond to patients with missing observations. From this plot we see the score
was usually an increasing function of time. Also, the score increased much faster
at the beginning of the study than towards the end and some patients achieved their
maximum score sooner than others. The achieved score at the end of 9 months and the
rate at which this score was achieved varied across the subjects. In general, however,
the responses exhibited similarly shaped curves.
Our aim is to model the recovery rate and the bounds by modelling the responses
at the four time points jointly. In this context, we adjust for the explanatory variables
gender, age and randomisation group. We use the explanatory variable randomisation
3
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Randomisation Groups (N = 553)
Time Tubigrip BKC Aircast Bledsoe Boot
Baseline
Mean 40.3 41.8 38.8 41.1
SD 14.1 16.4 15.1 16.9
4 weeks
Mean 60.7 67.4 62.8 61.6
SD 19.5 19.0 20.5 20.7
12 weeks
Mean 70.0 76.0 73.8 75.1
SD 20.5 18.4 20.6 20.4
39 weeks
Mean 80.4 82.8 81.0 81.2
SD 20.4 17.0 20.3 19.0
Table 1: Summary Statistics (SD: standard deviation) for the FAOSS-score and the different
randomisation groups and time points.
group rather than the treatment group because the analysis will be performed on an
intention-to-treat basis, i.e. all participants are analysed in the groups to which they
were randomised, regardless of the treatment that they received. The randomisation
groups were generally well matched in terms of gender and age. There was a slightly
larger number of males in the BKC group. Overall there was a greater proportion of
men (58%) than women (42%). The mean age of participants was 30 years (SD 10.8,
median 27, range 16− 72). Summary statistics for the FAOSS-score and the different
randomisation groups and time points are given in Table 1.
Statistical Model
This setting poses several challenges for a statistical model. We need to model the
rate of improvement; take into account the bounded nature of the score; model the
repeated measurements jointly and handle the missing data. Here, we will focus on
all challenges but the last. We will assume an ignorable missingness process and base
inference on the observed likelihood.12,13 For further discussion about the missing
data issue for the CAST study we refer to two papers.14,15
Let yi = (yi,0; yi,4; yi,12; yi,39)> denote the response vector of subject i ∈ {1, ..., 553},
where yi is a realisation of the random vector Yi. As the score is on a continu-
ous scale, we assumed an underlying normal distribution. That is Yi is multivari-
ate normal distributed and we denote the joint outcome vector for all subjects by
Y = (Y>1 , ...,Y
>
553)
>.
Furthermore, let Xi = (xi,0;xi,4;xi,12;xi,39)> be the matrix of explanatory vari-
ables for subject i ∈ {1, ..., 553}. The randomisation group is denoted by ηi ∈
{1, 2, 3, 4}, where ηi = 1 corresponds to Tubigrip, ηi = 2 to BKC, ηi = 3 to Air-
cast brace and finally ηi = 4 to Bledsoe boot. We propose the following model for the
outcome process
Yi|Ui ∼ N4
(
µi, σ
2I
)
;
Ui ∼ N (0,D2); (1)
µij = g(xij , θi) for j ∈ {0, 4, 12, 39}.
The mean component µij of the normal distribution is described by the non-linear
model function g. Moreover, I is the four-dimensional identity matrix and the param-
eter vector θi = (θ>, Ui)> varies across subjects. Here, θ denotes the fixed effects and
Ui the random subject-specific effect. Assuming that θi varies for different subjects
4
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reflects our observation that patients share the same general shape of the response
curve. However, the baseline values and the achieved scores at the end of the study
vary from patient to patient. In order to account for this inter-individual variation,
but also for the intra-individual correlation, regression parameters are assumed to
vary for different patients according to an underlying unobservable process Ui. In
this way we distinguish between the two sources of variation: the within-individual
variation σ2 and the between-individual variation D2. This unobservable quantity Ui
is patient-specific and measures the deviation from the average evolution, which all
patients share. For convenience we omit the i-subscript for θi in the derivation of the
non-linear model function g(xij , θ) = µij .
The FAOSS score is increasing over time and bounded, thus motivating our pro-
posal that the recovery rate should change over time. We expect a very low rate of
recovery when patients suffer from extreme symptoms, in particular yij = 0 implies a
recovery rate of zero. This is motivated by the fact that worst symptoms indicate a
very swollen and stiff ankle, which delays the start of recovery. Additionally, we know
that the recovery rate is zero when the upper bound of the score is achieved. This
means that the rate of recovery at a certain time point depends on the distance of the
current score to the lower and the upper bound. In mathematical terms, we expect
the rate of improvement in a given time interval, i.e. g′(xij , θ), to be proportional to
the current score, g(xij , θ), and the still achievable score [max{g(xij , θ)} − g(xij , θ)].
Hence, we are interested in solving the differential equation
g′(xij , θ) = κηi g(xij , θ) [max{g(xij , θ)} − g(xij , θ)],
where κηi for ηi ∈ {1, 2, 3, 4} is the treatment-specific proportion-factor. Note that
this relation formulates our assumptions above in mathematical terms, as the deriva-
tive of a curve at a certain point measures how a function changes at that point and
thus corresponds to the rate of change. Reducing the problem to xij = tj for simplicity
yields
g(xij , θ) =
β1
exp{−β2,ηi tj}
(
β1
β0
− 1
)
+ 1
.
In this model β0 denotes the intercept, β1 the upper bound, i.e. maximum achievable
score, and β2,ηi = κηi · β1 the treatment specific recovery rate of the outcome curve.
However, previous analyses4 and exploratory analysis have shown that the scores and
the rate of recovery depend on age and gender of the patients. Thus, our aim is to
adjust for these covariates. Incorporating the explanatory variables ai = agei − 27
(age centered around the median) and gender sexi ∈ {f,m} (f female, m male) is
straightforward; and in order to capture the inter-individual variation, we extend this
model to a non-linear mixed model by adding the subject-specific quantity Ui:16
g(xij ,θi)=
β1+α1 ai+γ1 1(sexi=f)
exp
{
−
(
[β21+β2,ηi 1(ηi 6=1)]+α2 ai+γ2 1(sexi=f)
)
·tj
}(
β1+α1·ai+γ1 1(sexi=f)
β0+α0 ai+γ0 1(sexi=f)
−1
)
+1
+ Ui
= µ˜ij + Ui, (2)
where 1(ηi 6= 1) and 1(sexi = f) are one if ηi 6= 1 or sexi = f respectively and
zero otherwise. Note that it is possible to include further explanatory variables. The
interpretation of all parameters is straightforward:
• β0 +α0 ai + γ0 1(sexi = f) describes the intercept, where α0 indicates the effect
of age on the intercept. For female patients the intercept differs by γ0 compared
5
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Parameter Est. CI P-val.
β0 41.11 [39.59,42.63] -
β1 82.64 [80.71,84.57] -
β21 0.29 [0.23,0.36] -
β22 0.12 [0.04,0.20] 0.0036
β23 0.07 [-0.01,0.14] 0.0798
β24 0.001 [-0.07,0.07]] 0.9780
α1 -0.24 [-0.37,-0.11] 0.0004
α2 -0.01 [-0.01,-0.002] < 0.0001
γ1 -5.34 [-8.18,-2.50] 0.0002
γ2 -0.06 [-0.12,-0.004] 0.0353
σ2 13.63 [13.11,14.14] -
D2 12.00 [11.01,13.00] -
Table 2: Overview of the parameter estimates and confidence intervals (CI) of θ for model (1)
based on the assumptions of an ignorable missingness process. The p-values are reported only for
the components of θ that might be zero.
to male patients.
• β1 +α1 ai + γ1 1(sexi = f) describes the maximum score (upper bound), α1 the
effect of age on this upper bound and γ1 the effect of being a female patient.
In particular, this model accounts for the bounded nature of the score. As time
increases a maximum score, varying according to age and gender, is achieved.
• [β21 +β2,ηi 1(ηi 6= 1)]+α2 ai+γ2 1(sexi = f) indicates the rate of improvement,
i.e. how fast the upper bound is achieved. This rate depends on the randomisa-
tion group ηi, age and gender. For ηi ∈ {2, 3, 4} the parameters β2,ηi denote the
contrast to, or increase from, the treatment slope of Tubigrip, i.e. β21.
Note that we could also incorporate a treatment specific effect on the upper bound.
However, extending the model reveals that such an effect is non-significant. Due to
the randomisation it is not sensible to add an treatment effect on the intercept term.
By adding the subject-specific quantity Ui in equation (2) we assume that the
intercept and the upper bound vary across patients, but not the rate of recovery.
That is, dependent on the patient-specific quantity the recovery curve is assumed to
shift upwards or downwards. However, the shape of the curve remains unchanged.
The mean for an average person i, that is with Ui = 0, for time point j is given by
µ˜ij , see equation (2).
Analyses based on the assumption of ignorability lead us to use model (2) without
any age- and gender-effect on the intercept. Hence, the parameters of the model are
θi = (θ>, Ui)> with θ = (β0, β1, β21, β22, β23, β24, α1, α2, γ1, γ2, σ,D)>.
This model can be reformulated in terms of the multivariate normal model with
a compound symmetry covariance structure. Let I be the identity matrix and J a
square matrix with all elements unity. Using the notation introduced in equation (2)
and µ˜i = (µ˜i0, µ˜i4, µ˜i12, µ˜i39)> we obtain:
Yi ∼ N4 (µ˜i,Σ ) where Σ = σ2 I +D2 J .
In particular, the correlation between measurements on an individual at different times
is given by D2/(σ2 + D2). The maximum likelihood estimate θˆ based on the joint
observed likelihood can be calculated through the Newton-Raphson method, which is
e.g. implemented in the SAS-procedure NLMIXED.17 The parameter estimates for the
model defined in equations (1) and (2) are summarized in Table 2.
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a) Recovery for age = 37 years b) Recovery for age = 66 years c) Recovery for Tubigrip
Figure 2: a) Fitted recovery curve versus time for the different randomisation groups and 37 year
old male patients. b) Fitted recovery curve versus time for the different randomisation groups and
66 year old male patients. c) Fitted FAOS-score versus time for different genders, age classes and
Tubigrip. The age groups were classified according to the first (21 years) and third (37 years)
quantiles.
Results
The interpretation of all parameters is straightforward. The intercept for an average
patient, i.e. the patient-specific quantity is zero, is given by βˆ0 = 41.11. The maximum
achievable score for an average person is given by βˆ1 = 82.64, but with a negative age-
effect and the upper bound for female patients is in average approximately 5 score
points lower than for male patients. Using these point estimates and allowing for the
age range of 16 to 72 implies that the upper bound for male patients varied between
73 and 85 score points, whereas for an average female patient the upper bound lay
between 68 and 80. Furthermore, we observe a negative age effect on the rate of
improvement, i.e. older participants recovered less fast than younger patients. In
addition, female patients recovered less fast than male patients as γˆ2 < 0. Generally
this means that the maximum achievable score for older and female patients was lower
than for younger and male patients. In particular, this implies that older and female
patients were less likely to recover completely from a severe sprain with the treatment
options tested in this trial.
The standard deviations reflecting the within- and between-patient variations are of
the same magnitude. Note that the between-subject variation D2 drives the estimation
of the subject-specific effect Ui.18
Regarding the treatment comparison, a significant difference in the rates of im-
provement between Tubigrip and BKC is detected. The rate of recovery for Aircast
brace was only marginally higher than Tubigrip. There was no significant difference in
recovery rates between Tubigrip and Bledsoe boot. The fitted curves for the different
randomisation groups for an average male patients of age 37 or 66 are shown in Fig-
ure 2a and Figure 2b respectively. Independent of the randomisation group, patients
ended at the same score. However, the rate at which they achieved the upper bound
differed substantially, in particular for older patients. Note that the fitted curves for
Tubigrip and Bledsoe are indistinguishable due to the insignificant treatment differ-
ence. These two plots also show the difference in the upper bounds dependent on
age. The dependence of the recovery rate and the upper bound on age and gender is
visualized for the randomisation group Tubigrip in Figure 2c.
In order to capture the interplay between the covariate effects of age, gender and
randomisation groups with the bounded nature of the score, we present the average
7
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Age Gender Treatment weeks 0-4 weeks 4-12 weeks 12-39
Est. CI Est. CI Est. CI
16 years
female
Tubigrip 20.3 [15.9,24.8] 16.1 [13.1,19.1] 2.4 [0.1,4.6]
BKC 26.2 [22.4,30.0] 12.0 [8.6,15.5] 0.6 [-0.03,1.2]
Aircast 23.8 [20.1,27.5] 13.9 [10.8,17.0] 1.1 [0.1,2.0]
Bledsoe 20.4 [16.3,24.5] 16.1 [13.2,18.9] 2.3 [0.3,4.4]
male
Tubigrip 26.2 [21.9,30.4] 16.6 [13.1,20.1] 1.4 [0.1,2.7]
BKC 32.0 [28.5,35.4] 11.8 [8.5,15.1] 0.3 [0.01,0.7]
Aircast 29.7 [25.9,33.4] 13.8 [10.4,17.3] 0.6 [0.04,1.2]
Bledsoe 26.2 [23.0,29.5] 16.5 [13.9,19.2] 1.4 [0.4,2.3]
21 years
female
Tubigrip 18.4 [14.4,22.5] 16.2 [13.9,18.5] 1.3 [0.5,5.6]
BKC 24.4 [20.8,28.1] 12.4 [9.2,15.6] 0.4 [0.01,1.5]
Aircast 22.0 [18.5,25.5] 14.2 [11.5,16.9] 0.6 [0.2,2.5]
Bledsoe 18.5 [14.6,22.3] 16.1 [13.9,18.4] 1.3 [0.6,5.4]
male
Tubigrip 24.2 [20.2,28.2] 17.0 [14.0,19.9] 0.8 [0.3,3.3]
BKC 30.2 [26.8,33.5] 12.3 [9.2,15.4] 0.2 [0.03,0.8]
Aircast 27.8 [24.1,31.5] 14.3 [11.1,17.6] 0.4 [0.1,1.5]
Bledsoe 24.3 [21.1,27.4] 16.9 [14.6,19.2] 0.6 [0.7,2.9]
27 years
female
Tubigrip 16.2 [12.5,19.8] 16.0 [14.4,17.6] 4.0 [1.1,7.0]
BKC 22.3 [18.8,25.9] 12.8 [9.9,15.7] 1.0 [0.1,2.0]
Aircast 19.9 [16.5,23.2] 14.5 [12.2,16.8] 1.9 [0.4,3.3]
Bledsoe 16.2 [12.5,19.9] 16.0 [14.3,17.6] 4.0 [1.0,7.0]
male
Tubigrip 21.8 [18.1,25.6] 17.3 [14.9,19.6] 2.4 [0.6,4.2]
BKC 28.0 [24.7,31.4] 12.9 [9.9,15.9] 0.6 [0.1,1.1]
Aircast 25.6 [21.8,29.3] 14.9 [11.8,17.9] 1.1 [0.1,2.1]
Bledsoe 21.9 [18.8,25.0] 17.3 [15.3,19.2] 2.4 [1.0,3.8]
37 years
female
Tubigrip 12.4 [9.5,15.4] 14.9 [13.8,16.1] 6.4 [2.8,9.9]
BKC 18.9 [15.4,22.4] 13.3 [10.8,15.8] 1.7 [0.2,3.1]
Aircast 16.3 [13.0,19.6] 14.5 [12.7,16.3] 3.0 [0.8,5.2]
Bledsoe 12.5 [8.8,16.2] 15.0 [13.8,16.1] 6.3 [1.9,10.8]
male
Tubigrip 17.9 [14.4,21.4] 17.3 [15.7,18.9] 3.9 [1.4,6.5]
BKC 24.4 [20.8,28.0] 13.7 [10.8,16.7] 1.0 [0.1,1.9]
Aircast 21.8 [17.8,25.9] 15.5 [12.7,18.4] 1.8 [0.2,3.4]
Bledsoe 18.0 [14.6,21.3] 17.3 [15.7,18.9] 3.9 [1.4,6.4]
66 years
female
Tubigrip 2.3 [-1.3,5.9] 4.3 [-1.9,10.5] 10.9 [2.6,19.1]
BKC 9.2 [4.4,13.9] 11.4 [9.0,13.9] 6.3 [-0.3,12.8]
Aircast 6.3 [1.3,11.3] 9.7 [5.1,14.3] 10.1 [2.2,18.1]
Bledsoe 2.4 [-3.3,8.0] 4.4 [-5.2,14.0] 11.0 [-1.3,23.3]
male
Tubigrip 6.9 [1.9,11.8] 11.2 [5.8,16.5] 13.1 [5.2,21.0]
BKC 14.1 [8.5,19.6] 14.2 [11.3,17.1] 4.1 [-0.9,9.0]
Aircast 11.1 [4.7,17.5] 14.0 [11.3,16.8] 7.1 [-1.3,15.5]
Bledsoe 6.9 [0.7,13.1] 11.2 [4.7,17.7] 13.0 [3.3,22.7]
Table 3: Overview of the average improvements (Est.) between two adjacent time points for
different age groups, genders and randomisation groups. The age classes were classified according
to the first percentile (16 years), the first (21 years), second (27 years) and third (37 years) quantiles
and the 99th percentile (66 years). The confidence intervals are denoted by CI.
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female male
Age Treatment Weeks CI Weeks CI
16 years
Tubigrip 5.0 [3.6,6.3] 3.6 [2.8,4.3]
BKC 3.5 [2.8,4.3] 2.7 [2.2,3.1]
Aircast 4.0 [3.2,4.9] 3.0 [2.4,3.5]
Bledsoe 4.9 [3.7,6.2] 3.5 [3.0,4.1]
21 years
Tubigrip 5.6 [4.1,7.1] 3.9 [3.1,4.7]
BKC 3.9 [3.0,4.7] 2.9 [2.4,3.4]
Aircast 4.5 [3.5,5.4] 3.3 [2.7,3.9]
Bledsoe 5.6 [4.2,7.0] 3.9 [3.3,4.5]
27 years
Tubigrip 6.7 [4.9,8.4] 4.5 [3.6,5.4]
BKC 4.4 [3.4,5.4] 3.2 [2.6,3.8]
Aircast 5.2 [4.1,6.3] 3.7 [2.9,4.4]
Bledsoe 6.6 [4.9,8.4] 4.5 [3.7,5.2]
37 years
Tubigrip 9.3 [6.8,11.8] 5.8 [4.5,7.1]
BKC 5.6 [4.2,7.0] 3.9 [3.1,4.7]
Aircast 6.8 [5.1,8.5] 4.5 [3.4,5.6]
Bledsoe 9.3 [6.3,12.2] 5.7 [4.5,7.0]
66 years
Tubigrip 73.5 [-40.0,186.9] 18.4 [4.4,32.4]
BKC 17.1 [4.7,29.5] 8.3 [4.2,12.5]
Aircast 25.6 [2.2,49.1] 10.9 [3.9,18.0]
Bledsoe 71.5 [-96.3,239.4] 18.2 [1.4,35]
Table 4: An overview of the expected number of weeks to reach a score of 65 for different genders,
age groups and the four randomisation groups.
improvement between two adjacent time points dependent on these covariates, see
Table 3. The estimates for the improvements underline the large effect of age and
gender on the improvements. Comparing the score gain for 16 year old and 66 year
old patients shows that older patients recovered much more slowly than young patients.
Furthermore, the effect of the bounded score stands out. In the last time interval, the
improvement was generally much smaller than in the previous intervals. However, the
effect of the bounded score depended also on the age and gender. On average, older
and female patients needed longer to achieve their upper bound, which dependent on
age ranges between 68 and 80 score points. In fact, for an average person, i.e. Ui = 0,
we are able to calculate the expected time to achieve a certain score S based on the
fitted curves. For this purpose we need to rearrange equation (2) to solve for time
t(S):
t(S) =
−1
[β21 + β2,ηi 1(ηi 6= 1)] + α2 ai + γ2 1(sexi = f)
× log
 β1 + α1 ai + γ1 1(sexi = f)− S(β1 + α1 ai + γ1 1(sexi = f)
β0
− 1
)
· S

The estimated times to achieve a score of S = 65 are shown in Table 4. While a 16
year old male patient under Tubigrip needed approximately 4 weeks to achieve a score
of 65, a man at the age of 37 years needed in average 2 weeks longer. The difference for
66 year old patients is even more drastic. However, care should be taken in reporting
these results as for 66 year old female patients the maximum achievable score was
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nearly 68, which is close to S = 65 and thus leads to an imprecise estimation. This
is reflected in the wide confidence intervals. In general, however, we believe that this
information, together with the ability to quantify the expected upper bound per age
band and gender, could be of particular interest to patients.
Discussion
We have proposed a model for continuous, bounded and repeated measurements which
enables the investigation of covariate effects on the rate of change and the bounds.
The model belongs to the class of non-linear mixed models which have found many
biological applications, such as pharmacokinetic analysis, rate of clearance of a drug,
studies of growth to adult size and decay.16,19,20 However, to the best of our knowledge
they are not yet used in the health-care context. We argue that in our specific case
these models are preferable to standard techniques.
In the CAST study, we observed repeated measurements and thus a sensible model
needs to account for the variation among the measurements within a given patient and
the variation between different patients. The original analysis5,6 did not distinguish
between these two different sources of variation. Additionally, the repeated measure-
ments were not modelled jointly: the treatment differences were investigated for every
time point separately and it was not clear how to combine these estimates into a sin-
gle inference. This situation was even more complicated as the data were clustered
towards the end of the trial. Discrimination between treatments at these time points
was practically impossible. Moreover, no satisfactory description of the score evolution
over time for different age groups and genders was presented.
Furthermore, we argued that the traditional approach of transforming the data, for
example by using the log or logit transformation does not always resolve the problem
of a non-linear relationship of the response over time. We investigated several trans-
formations for the CAST study, but a non-linear relation with time persisted due to
the bounded nature of the outcome. Also the inclusion of higher order time effects
did not lead to a satisfying fit. Importantly, using transformations we were no longer
able to investigate covariate effects on the bounds.
Our model was derived on medical research grounds and reflects the knowledge
of experts in the specific research area. It enables a very flexible incorporation of
exploratory variables and is easy to interpret, which is a valuable advantage to the
alternative of data transformation. In addition, it accounts for the two different sources
of variation and enables us to model the upper bound, that is, final recovery, which
might be of particular interest to patients.
Fitting this model to the CAST data revealed that recovery was more rapid with
BKC than with Tubigrip. These results coincide with those of the original analysis,
but add to it by allowing the estimation of the time to recovery in each of the groups.
The results of this analysis re-enforce the results of the original CAST trial, in so
far as it provides further that interventions that immobilise the ankle, such as below
knee plaster, are more effective than those which permit early movement. These
conclusions are contrary to previous studies.21 Taking into account the considerable
variation in the costs for each treatment, these results might be relevant for the UK
National Health Service. Further, we show that older and female patients recovered
substantially more slowly than younger and male participants. Also the score at final
recovery for older female patients was lower than for young male patients, suggesting
that older female patients were less likely to recover completely from an acute soft
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tissue injury. We translated these findings into auxiliary information, such as the
expected time to achieve a certain score for different patient groups.
Although we believe that our model is superior to standard analysis techniques
applied in this field, we note that the model is limited by the covariance structure it
assumed for the outcome vector. We worked with a compound symmetry covariance
structure, which implied equal correlation of any two different measurements on the
same subject regardless of the length of the time interval between these measurements.
However, the design of the CAST study had unequally spaced time points and with
repeated measurements we expect more correlation when the measurements are closer
in time than when they are further apart. Additionally, with bounded data, corre-
lations increase as measurements reach the bounds regardless of the distance of the
measurements in time, thus complicating the situation even more. Further work con-
cerning modelling covariance structures for bounded continuous data is in progress.
Furthermore, we note that our analysis assumed an ignorable missingness process. A
sensitivity analysis scrutinizing this assumptions is available.14
Key Messages
• Non-linear models can be preferable to the transformation approach when deal-
ing with bounded data.
• For CAST, we confirm that the use of below knee cast is advantageous compared
to a tubular bandage in relation with the rate of recovery.
• We show that older and female patients recover substantially slower than younger
male patients and that older patients and female patients are less likely to recover
completely from a severe sprain.
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